Who Exports Acetaminophen from India — 266 Suppliers Behind a $232.0M Market
India's acetaminophen export market is supplied by 266 active exporters who collectively shipped $232.0M across 4,829 shipments. GRANULES INDIA LIMITED leads with a 56.1% market share, followed by ELYSIUM PHARMACEUTICALS LTD and SRI KRISHNA PHARMACEUTICALS LIMITED. The top 5 suppliers together control 79.6% of total export value, reflecting a concentrated market structure.
Top Acetaminophen Exporters from India — Ranked by Export Value
GRANULES INDIA LIMITED is the leading acetaminophen exporter from India, holding a 56.1% share of the $232.0M market across 4,829 shipments from 266 exporters. The top 5 suppliers — GRANULES INDIA LIMITED, ELYSIUM PHARMACEUTICALS LTD, SRI KRISHNA PHARMACEUTICALS LIMITED, MARKSANS PHARMA LIMITED, ELYSIUM PHARMACEUTICALS LIMITED — collectively control 79.6% of total export value, indicating a highly concentrated market. Individual shares are: GRANULES INDIA LIMITED (56.1%), ELYSIUM PHARMACEUTICALS LTD (11.0%), SRI KRISHNA PHARMACEUTICALS LIMITED (5.4%), MARKSANS PHARMA LIMITED (3.7%), ELYSIUM PHARMACEUTICALS LIMITED (3.4%).
Top Acetaminophen Exporters from India
Ranked by export value · 266 active suppliers · Indian Customs (DGFT) data
| # | Supplier & Formulations | Value | Ctry. | Share |
|---|---|---|---|---|
| 1 | GRANULES INDIA LIMITED ACETAMINOPHEN EXTENDED RELEASE TABLETS UACETAMINOPHEN EXTENDED RELEASE TABLETS USP 650MGACETAMINOPHEN TABLETS USP 500MG | $130.1M | 19 | 56.1% |
| 2 | ELYSIUM PHARMACEUTICALS LTD ACETAMINOPHEN EXTENDED RELEASE TABLETS UACETAMINOPHEN EXTENDED RELEASE TABLETS USP 650MGEXTRA STRENGTH ACETAMINOPHEN USP 500MG CAPLETS | $25.4M | 1 | 11.0% |
| 3 | SRI KRISHNA PHARMACEUTICALS LIMITED ACETAMINOPHEN TABLETS USP 500MGACETAMINOPHEN TABLETS USP 500MG(EASY TOACETAMINOPHEN SR TABLETS USP 650MG- BULK | $12.5M | 7 | 5.4% |
| 4 | MARKSANS PHARMA LIMITED ACETAMINOPHEN EXTENDED RELEASE TABLETS UACETAMINOPHEN EXTENDED RELEASE TABLETS USP 650MGEXTRA STRENGTH ACETAMINOPHEN USP 500MG CAPLETS | $8.7M | 3 | 3.7% |
| 5 | ELYSIUM PHARMACEUTICALS LIMITED ACETAMINOPHEN EXTENDED RELEASE TABLETS UACETAMINOPHEN EXTENDED RELEASE TABLETS USP 650MGEXTRA STRENGTH ACETAMINOPHEN USP 500MG CAPLETS | $7.9M | 1 | 3.4% |
| 6 | CAPLIN POINT LABORATORIES LIMITED METHOCARBAMOL AND ACETAMINOPHEN TABLETSACETAMINOPHEN ORAL SOLUTION 120MG/5ML (ACETAMINOPHEN TABLETS USP 500MG | $7.3M | 7 | 3.2% |
| 7 | APOTEX RESEARCH PRIVATE LIMITED ACETAMINOPHEN TABLETS USP 500MGACETAMINOPHEN TABLETS USP 500MG(EASY TOACETAMINOPHEN SR TABLETS USP 650MG- BULK | $3.7M | 1 | 1.6% |
| 8 | EUGIA PHARMA SPECIALITIES LIMITED ACETAMINOPHEN EXTENDED RELEASE TABLETS UACETAMINOPHEN EXTENDED RELEASE TABLETS USP 650MGEXTRA STRENGTH ACETAMINOPHEN USP 500MG CAPLETS | $3.7M | 1 | 1.6% |
| 9 | SOFTGEL HEALTHCARE PRIVATE LIMITED GRIPACHECK CAPS (ACETAMINOPHEN USP 325MGGRIPACHECK CAPSULES (ACETAMINOPHEN USP 3GRIPACHECK CAPS(ACETAMINOPHEN USP 325MG, | $2.5M | 4 | 1.1% |
| 10 | TRUECARE BIOMEDIX ACETAMINOPHEN EXTENDED RELEASE TABLETS UACETAMINOPHEN EXTENDED RELEASE TABLETS USP 650MGEXTRA STRENGTH ACETAMINOPHEN USP 500MG CAPLETS | $2.1M | 1 | 0.9% |
| 11 | GRANULES LIFE SCIENCES PRIVATE LIMITED ACETAMINOPHEN EXTENDED RELEASE TABLETS UACETAMINOPHEN EXTENDED RELEASE TABLETS USP 650MGACETAMINOPHEN TABLETS USP 500MG | $1.7M | 2 | 0.7% |
| 12 | LINCOLN PHARMACEUTICALS LTD ACETAMINOPHEN ORAL SOLUTION 125 MG/5 MLHARMLESS MEDICINES. ACETAMINOPHEN SUPPOS | $1.5M | 2 | 0.7% |
| 13 | MYLAN LABORATORIES LIMITED ACETAMINOPHEN EXTENDED RELEASE TABLETS UACETAMINOPHEN EXTENDED RELEASE TABLETS USP 650MGEXTRA STRENGTH ACETAMINOPHEN USP 500MG CAPLETS | $1.4M | 1 | 0.6% |
| 14 | MEDICO REMEDIES LIMITED ACETAMINOPHEN ORAL SOLUTION 120MG/5ML (ACETAMINOPHEN TABLETS USP 500MGACETEFF | $1.4M | 5 | 0.6% |
| 15 | ACME GENERICS PRIVATE LIMITED ACETAMINOPHEN TABLETS USP 500MGACETAMINOPHEN TABLETS USP 500MG(EASY TOACETAMINOPHEN SR TABLETS USP 650MG- BULK | $1.3M | 1 | 0.6% |
Related Analysis
Supplier Certification & Compliance Matrix
FDA, WHO-GMP, and EU GMP status for top Acetaminophen exporters
| Supplier | US FDA | WHO-GMP | EU GMP | ANDAs | Notes |
|---|---|---|---|---|---|
| Granules India Limited | Warning Letter issued in | Unknown | Unknown | 69 approvals as of January 2025 | FDA cited significant cGMP violations, including inadequate cleaning procedures |
| Eugia Pharma Specialities Limited | Warning Letter issued in | Unknown | Unknown | Not verified | FDA identified significant cGMP violations during inspection. |
| Sri Krishna Pharmaceuticals Limited | Warning Letter issued in | Unknown | Unknown | Not verified | FDA cited data manipulation and integrity issues. |
| Granules Life Sciences Private Limited | Approved in November 2025 | Unknown | Unknown | Not verified | Received first FDA approval for Hyderabad facility. |
| Mylan Laboratories Limited | Warning Letter issued in | Unknown | Unknown | Not verified | FDA cited cGMP violations. |
| Glenmark Pharmaceuticals Limited | Warning Letter issued in | Unknown | Unknown | Not verified | FDA identified significant cGMP violations. |
| Global Pharma Healthcare Private Limited | Warning Letter issued in | Unknown | Unknown | Not verified | FDA cited significant cGMP violations. |
| GPT Pharmaceuticals Private Ltd | Warning Letter issued in | Unknown | Unknown | Not verified | FDA cited significant cGMP violations. |
TransData Nexus reviewed the regulatory standing of 8 leading Acetaminophen exporters from India. 1 hold US FDA facility approvals, 0 maintain WHO-GMP certification, and 0 are EU GMP compliant. 7 suppliers have received FDA regulatory actions — buyers should verify current remediation status before placing orders. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.
Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.
TransData Nexus Research · Mar 2026
Manufacturing Hub Analysis — Vendor Proximity
India's pharmaceutical clusters relevant to Acetaminophen sourcing
1Hyderabad — Bulk Drug Capital
Hyderabad, often referred to as the "Bulk Drug Capital of India," is a pivotal hub for active pharmaceutical ingredients (APIs) production. The city hosts major manufacturers like Granules India Limited and Sri Krishna Pharmaceuticals Ltd. Granules India, headquartered in Hyderabad, operates one of the world's largest paracetamol facilities in Visakhapatnam, with an annual capacity exceeding 30,000 metric tons. This facility's backward integration into key raw materials like para-aminophenol (PAP) minimizes supply chain risks and enhances cost efficiency. Similarly, Sri Krishna Pharmaceuticals, established in 1974, began as a pioneer in bulk acetaminophen manufacturing and has grown into a vertically integrated producer of multiple first-line-of-defense APIs.
2Ahmedabad-Vadodara — Formulations Hub
The Ahmedabad-Vadodara corridor in Gujarat is renowned for its pharmaceutical formulations industry. This region is home to over 3,300 pharmaceutical units, making it one of India's largest pharmaceutical manufacturing clusters. Companies in this area focus on producing finished dosage forms, including tablets and capsules containing acetaminophen, catering to both domestic and international markets. The well-established infrastructure and regulatory compliance in this region make it a preferred destination for pharmaceutical formulations.
3Mumbai-Thane-Raigad — Export Gateway
The Mumbai-Thane-Raigad belt in Maharashtra serves as a critical export gateway for pharmaceuticals. With approximately 929 pharmaceutical units, this region facilitates the export of acetaminophen and other drugs to global markets. The proximity to major ports and international airports enhances logistical efficiency, enabling timely delivery of pharmaceutical products worldwide.
4Baddi-Nalagarh — Tax Incentive Zone
Baddi-Nalagarh in Himachal Pradesh has emerged as a significant pharmaceutical manufacturing zone, housing around 555 pharmaceutical units. The region offers tax incentives and a conducive business environment, attracting numerous pharmaceutical companies. While primarily known for formulations, some units also engage in API production, including acetaminophen.
5Sourcing Recommendations
- Diversify Supplier Base: Engage with multiple suppliers across different regions to mitigate risks associated with regional disruptions.
- Assess Regulatory Compliance: Ensure suppliers adhere to international quality standards and have necessary certifications from regulatory bodies like the US FDA and WHO-GMP.
- Evaluate Supply Chain Integration: Prefer suppliers with backward integration into key raw materials to reduce dependency on external sources and enhance cost efficiency.
- Monitor Market Dynamics: Stay informed about regional developments, such as regulatory changes or infrastructure improvements, that could impact supply chain stability and cost structures.
Recent M&A, Collaborations & Capacity Expansions
Industry developments among top Acetaminophen exporters from India
Marksans Pharma Limited — Marksans Pharma acquires Tevapharm India's Goa facility
Marksans Pharma entered into a Business Transfer Agreement with Tevapharm India Private Limited to acquire its bulk pharmaceutical formulations manufacturing facility in Verna, Goa. The site holds approvals from the European Union, Health Canada, and the Japanese Health Authority. - IMPACT: This acquisition is expected to double Marksans Pharma's manufacturing capacity, potentially enhancing their acetaminophen production capabilities.
Impact: This acquisition is expected to double Marksans Pharma's manufacturing capacity, potentially enhancing their acetaminophen production capabilities.
Marksans Pharma Limited — Marksans Pharma receives US FDA approval for Guaifenesin Extended-Release Tablets
The company received final approval from the US FDA for its Abbreviated New Drug Application (ANDA) for Guaifenesin Extended-Release Tablets, 600 mg and 1200 mg (OTC), bioequivalent to Mucinex Extended-Release Tablets. - IMPACT: While this approval pertains to Guaifenesin, it demonstrates Marksans Pharma's expanding presence in the US market, which may indirectly influence their acetaminophen export strategies.
Impact: While this approval pertains to Guaifenesin, it demonstrates Marksans Pharma's expanding presence in the US market, which may indirectly influence their acetaminophen export strategies.
Marksans Pharma Limited — Marksans Pharma receives US FDA approval for Esomeprazole Magnesium Delayed-Release Capsules
The company received US FDA approval for Esomeprazole Magnesium Delayed-Release Capsules USP, 20 mg (OTC), bioequivalent to Nexium 24 HR Delayed Release Capsules. - IMPACT: This approval further strengthens Marksans Pharma's product portfolio in the US, potentially impacting their overall export dynamics, including acetaminophen.
Impact: This approval further strengthens Marksans Pharma's product portfolio in the US, potentially impacting their overall export dynamics, including acetaminophen.
Common Questions — Acetaminophen Suppliers from India
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which acetaminophen supplier from India is the most reliable for bulk orders?
Based on shipment frequency and export consistency, GRANULES INDIA LIMITED leads with 1,700 recorded shipments worth $130.1M. ELYSIUM PHARMACEUTICALS LTD (390 shipments) and SRI KRISHNA PHARMACEUTICALS LIMITED (138 shipments) are also established high-volume exporters.
Q How many acetaminophen manufacturers are there in India?
India has 266 active acetaminophen exporters with a combined export market of $232.0M across 4,829 shipments to 104 countries. The top 5 suppliers hold 79.6% of total export value.
Q What certifications should I verify?
Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).
Q What is the typical price range for acetaminophen from India?
Average FOB unit price: $17.97 per unit, ranging from $0.00 to $709.13. Average shipment value: $48.0K.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Supplier Ranking: 266 verified Indian exporters of Acetaminophen ranked by capped export value from DGFT shipping bill records.
- 2.Export Value Analysis: Total export value aggregated from 4,829 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Market Concentration: Supplier market share and geographic reach analyzed across 104 destination countries.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
4,829 Verified Shipments
266 exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists